Skip to main content

Table 3 AUC measurements of gastrointestinal symptoms following consumption of low FODMAP ONS beverages and positive control

From: Gastrointestinal tolerance of low FODMAP oral nutrition supplements in healthy human subjects: a randomized controlled trial

 

Positive Control

Low FODMAP A

Low FODMAP B

Low FODMAP C

 

Symptom

Mean

Mean

Mean

Mean

SE

P value

Baseline- 4 h post consumption

 Gas/bloating

0.25

−0.08

0.61

−0.21

0.37

0.40

 Nausea

0.24

−0.06

0.08

−0.23

0.23

0.79

 Flatulence

0.24

−0.20

0.13

0.27

0.33

0.77

 Diarrhea/loose stools

0.00

−0.18

0.02

0.00

0.09

0.36

 Constipation

0.24

−0.18

0.02

0.05

0.09

0.29

 GI rumbling

0.21

−0.12

−0.15

0.04

0.45

0.93

 GI cramping

−0.08

0.07

−0.07

−0.08

0.14

0.82

 Composite GI symptom score

0.61

−0.71

0.61

−0.17

0.82

0.61

Baseline- 48 h post consumption

 Gas/bloating

−2.42

−5.89

4.03

−5.83

3.73

0.21

 Nausea

−6.07

−4.25

−0.77

−4.42

3.94

0.81

 Flatulence

−1.02

−4.49

2.99

1.23

4.04

0.59

 Diarrhea/loose stools

2.67

−1.13

0.50

0.95

1.79

0.52

 Constipation

0.02

−1.42

1.36

0.05

1.32

0.54

 GI rumbling

−4.26

−9.64

−11.20

−5.77

5.81

0.82

 GI cramping

−2.18

0.07

−1.69

−1.32

2.02

0.88

 Composite GI symptom score

−10.92

−26.24

−4.82

−13.40

9.91

0.48